AS

Alan Shuldiner

RP Regeneron Pharmaceuticals: 3 patents #31 of 271Top 15%
UB University Of Maryland, Baltimore: 2 patents #5 of 126Top 4%
📍 Baltimore, MD: #28 of 575 inventorsTop 5%
🗺 Maryland: #206 of 3,746 inventorsTop 6%
Overall (2022): #89,988 of 548,613Top 20%
3
Patents 2022

Issued Patents 2022

Showing 1–3 of 3 patents

Patent #TitleCo-InventorsDate
11504390 Treatment of increased lipid levels with sterol regulatory element binding transcription factor 1 (SREBF1) inhibitors Nehal Gosalia, Cristopher Van Hout, Da-Wei Gong, James Perry 2022-11-22
11485958 HSD17B13 variants and uses thereof Noura S. Abul-Husn, Omri GOTTESMAN, Alexander Li, Xiping Cheng, Yurong Xin +5 more 2022-11-01
11331332 Treatment of increased lipid levels with sterol regulatory element binding protein cleavage-activating protein (SCAP) inhibitors Da-Wei Gong, James Perry, Nehal Gosalia, Cristopher Van Hout 2022-05-17